Silverleafe Capital Partners, LLC Eli Lilly & CO Transaction History

Silverleafe Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 03, 2019	SELL	$110.79 - $129.32 $242,851 - $283,469	-2,192 Closed	0 $0
Q1 2019 Apr 10, 2019	BUY	$111.31 - $131.02 $42,520 - $50,049	382 Added 21.1%	2,192 $284,000
Q4 2018 Jan 04, 2019	BUY	$105.9 - $118.64 $191,679 - $214,738	1,810 New	1,810 $209,000

4,011

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Silverleafe Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverleafe Capital Partners, LLC with notifications on news.